Farmson Receives US FDA Certification for Paracetamol

Farmson Basic Drugs Pvt Ltd proudly announces its US FDA certification for Paracetamol API, a significant milestone affirming its commitment to global quality, regulatory excellence, and manufacturing leadership. Discover what this certification means for Farmson’s role in international pharmaceutical supply, its vision for global healthcare, and how it reinforces trust in every batch we produce.  

For More Information Visit: https://www.farmson.com/blogs/farmson-receives-us-fda-certification-for-paracetamol/

Farmson Basic Drugs Private Limited holds EU GMP Certification for Paracetamol DC

Farmson Basic Drugs Pvt Ltd Unit II has earned the esteemed EU GMP certification for its Directly Compressible Paracetamol a major leap in its journey from API leadership to value-added pharmaceutical solutions. This achievement underscores Farmson’s commitment to global quality standards, offering formulation partners across Europe a compliant, efficient, and reliable Paracetamol DC solution backed by vertical integration and proven manufacturing excellence.

For More Information visit: https://www.farmson.com/blogs/farmson-basic-drugs-private-limited-holds-eu-gmp-certification-for-paracetamol-dc/

Farmson Basic Drugs – Global Leader in API Paracetamol Manufacturing

Farmson Basic Drugs is the world’s leading manufacturer of Paracetamol (Acetaminophen) API, committed to setting industry benchmarks through innovation, quality, and sustainability. With decades of pharmaceutical excellence, Farmson serves top global clients while upholding the highest standards in manufacturing, regulatory compliance, and environmental responsibility. From India to the world, we power health with trusted formulations.

Explore more: www.farmson.com